For six long years, my children suffered from frightening psychiatric symptoms that resisted treatment. When a surprising ...

One of the uncomfortable truths about multiple sclerosis is that the part of the brain likely to reveal the most about the ...

Pain remains one of the most prevalent and disabling non-motor consequences of neurological disease, yet it continues to be ...

Bioscience Co., Ltd. Class H ( (HK:2493)) has shared an update. Mabwell (Shanghai) Bioscience Co., Ltd. has received approval from China’s National Medical Products Administration to begin clinical ...

Tole combines ultrasound and AI to improve motor neuron disease diagnosis, reducing reliance on invasive procedures.

TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant schizophrenia. The Phase 2 ...

Once rapidly fatal, neglected, and orphan diseases without approved therapeutic options, systemic amyloidoses are now highly ...

Prilenia Therapeutics B.V. and Ferreri today announced initiation of the confirmatory PRECISE-HD study (Pridopidine Phase 3 Study to Establish Clinical Impact and Safety in Huntington's Disease (HD) ...

PRECISE-HD (Pridopidine Phase 3 Study to Establish Clinical Impact and Safety in Huntington's Disease (HD)) is designed to further evaluate the efficacy and safety of pridopidine, an oral investigatio ...

Prepare for Manipal Entrance Test with ease with Edugraph Colleges! Our exam page offers detailed information on the syllabus, helping you stay ahead of the competition. Join us today and prepare with ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctv1220nc1.4 https ...